Status:
COMPLETED
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Diabetes Mellitus Type 2
Eligibility:
All Genders
30-75 years
Phase:
PHASE2
Brief Summary
This study will evaluate the efficacy, safety, tolerability, and pharmacokinetics of oral GK Activator (2), compared to placebo, in patients with type 2 diabetes mellitus. The anticipated time on stud...
Eligibility Criteria
Inclusion
- adult patients 30-75 years of age;
- type 2 diabetes mellitus for \>3 months before screening;
- treatment-naive, inadequately controlled diabetes despite diet and exercise, or inadequately controlled diabetes in patients on monotherapy or combination therapy (maximum of 2 oral anti-hyperglycemic medications).
Exclusion
- type 1 diabetes mellitus;
- women who are pregnant, breast-feeding or not using adequate contraceptive methods.
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
267 Patients enrolled
Trial Details
Trial ID
NCT00266240
Start Date
November 1 2005
End Date
May 1 2007
Last Update
November 2 2016
Active Locations (44)
Enter a location and click search to find clinical trials sorted by distance.
1
Tucson, Arizona, United States, 85723
2
Pine Bluff, Arkansas, United States, 71603
3
Chula Vista, California, United States, 91911
4
Spring Valley, California, United States, 91978